Document ID: chunk:federal_register_of_legislation:F2024C01228:front:0:p8
Version: federal_register_of_legislation:F2024C01228
Segment Type: other
Provision Reference: 
Character Range: 18318–21179

but less than 3 years; or
 (b) a person who is at least 6 months but less than 3 years
 (i) who:
 (A) has cardiac disease including cyanotic congenital heart disease, coronary artery disease and congestive heart failure; or
 (B) has a chronic respiratory condition including suppurative lung disease, bronchiectasis, cystic fibrosis, chronic obstructive pulmonary disease, chronic emphysema and severe asthma; or
 (C) has another chronic illness requiring regular medical follow‑up or hospitalisation in the preceding year, including diabetes mellitus, chronic metabolic diseases, chronic renal failure, haemoglobinopathies and impaired immunity (including drug‑induced immune impairment); or
 (D) has a chronic neurological condition, including multiple sclerosis, spinal cord injuries, seizure disorders or other neuromuscular disorders; or
 (E) has impaired immunity, including HIV infection; or
 (F) is receiving long‑term aspirin therapy.

 (9A) For item 210A of Schedule 1, a designated vaccine mentioned in that item may be provided to any of the following persons:
 (aa) a child who is at least 6 months of age but less than 5 years of age; or
 (a) an Aboriginal or Torres Strait Islander who is at least 6 months of age but less than 65 years of age;
 (b) a person who is at least 6 months of age but less than 65 years of age and who:
 (i) has cardiac disease including cyanotic congenital heart disease, coronary artery disease and congestive heart failure; or
 (ii) has a chronic respiratory condition including suppurative lung disease, bronchiectasis, cystic fibrosis, chronic obstructive pulmonary disease, chronic emphysema and severe asthma; or
 (iii) has another chronic illness requiring regular medical follow‑up or hospitalisation in the preceding year, including diabetes mellitus, chronic metabolic diseases, chronic renal failure, haemoglobinopathies and impaired immunity (including drug‑induced immune impairment); or
 (iv) has a chronic neurological condition, including multiple sclerosis, spinal cord injuries, seizure disorders or other neuromuscular disorders; or
 (v) has impaired immunity, including HIV infection;
 (c) a person who is at least 6 months of age but less than 11 years of age and is receiving long‑term aspirin therapy;
 (d) a woman who is pregnant.

 (10) For an item in Schedule 1 that specifies circumstances in which a designated vaccine may be provided to a child that include the specification of an age not more than 4 years, the vaccine may be provided to a child if:
 (a) the child did not receive the vaccine at the age specified in the item; and
 (b) the child is less than 10 years of age.

     Note: For example, if a vaccine is intended to be provided for the immunisation of a child at 2 months, 4 months and 6 months of age but the child does not receive the vaccine at those ages, the doses of